Synthesis and structure–activity relationship of mono-indole-, bis-indole-, and tris-indole-based sulfonamides as potential anticancer agents
- 28 June 2013
- journal article
- research article
- Published by Springer Nature in Molecular Diversity
- Vol. 17 (3) , 595-604
Abstract
A series of arylsulfonyl mono-indoles (10–15), bis-indoles (16–27), and tris-indoles (28–32) have been synthesized and evaluated for their cytotoxicity toward four human cancer cell lines including HuCCA-1 (cholangiocarcinoma), HepG2 (hepatocellular carcinoma), A-549 (lung carcinoma), and MOLT-3 (lymphoblastic leukemia). Most of the synthesized indoles displayed cytotoxicity against the MOLT-3 cell line except for analogs 16, 17, and 32. Significantly, the \(N\)-sulfonylphenolic bis-indole series (18–27) and the \(N\)-chlorobenzenesulfonyl tris-indole (30) showed higher antiproliferative activity against HepG2 cell than the reference drug, etoposide. Promisingly, the \(N\)-chlorobenzenesulfonyl bis-indole (20) and tris-indole (30) provided 3-fold and 2-fold stronger activity, respectively, against HepG2 cell than etoposide. Moreover, the phenolic bis-indole (20) was also shown to be the most potent cytotoxic agent against HuCCA-1 and A-549 cell lines with \(\text{ IC }_{50}\) values of 7.75 and \(8.74\, \upmu \text{ M }\), respectively. The tris-indole analogs 28, 29, and 31 also exhibited selectivity against MOLT-3 cell. The findings disclosed that \(N\)-arylsulfonyl bis-indoles-bearing phenolic groups are potentially interesting lead pharmacophores of anticancer agents that should be further investigated in more detail.
Keywords
This publication has 21 references indexed in Scilit:
- Iodine-catalyzed condensation of isatin with indoles: A facile synthesis of di(indolyl)indolin-2-ones and evaluation of their cytotoxicityBioorganic & Medicinal Chemistry Letters, 2012
- Simple indole alkaloids and those with a nonrearranged monoterpenoid unitNatural Product Reports, 2010
- Marine Indole Alkaloids: Potential New Drug Leads for the Control of Depression and AnxietyChemical Reviews, 2010
- Bis- and Trisindolylmethanes (BIMs and TIMs)Chemical Reviews, 2009
- Trisindoline synthesis and anticancer activityBiochemical and Biophysical Research Communications, 2008
- Cancer chemotherapy with indole-3-carbinol, bis(3′-indolyl)methane and synthetic analogsCancer Letters, 2008
- Gene Expression Profiling Revealed Survivin as a Target of 3,3′-Diindolylmethane-Induced Cell Growth Inhibition and Apoptosis in Breast Cancer CellsCancer Research, 2006
- Indole alkaloid marine natural products: An established source of cancer drug leads with considerable promise for the control of parasitic, neurological and other diseasesLife Sciences, 2005
- Recent developments in indole ring synthesis—methodology and applicationsJournal of the Chemical Society, Perkin Transactions 1, 2000
- Convolutamydine A, a novel bioactive hydroxyoxindole alkaloid from marine bryozoan Amathia convolutaTetrahedron Letters, 1995